10 November 2020 - New Zealand researchers are hopeful and optimistic as Pfizer and BioNTech report success in their COVID-19 vaccine study.
An early peek at the data suggests the vaccine may be a surprisingly robust 90% effective at preventing COVID-19, putting the company on track to apply later this month for emergency use approval from the FDA.
But there are still a lot of unknowns.